Weekly Recap | INSILICO -0.47%, most brokers rate it buyWeekly Review·Nov 14, 2026 at 05:31 AM03696+1.35%
Insilico Medicine Subsidiary Partners With Luoxin Pharmaceuticals on AI-Powered Drug DiscoveryPUBT·Nov 13, 2026 at 08:36 AM03696+1.35%002793-0.52%